Analyst generally are rating Neuren at around $30 value today with significant upside as they derisk. A share buyback anywhere below $20 is exceptional value given the cash on hand already along with growing cashflow forecast and more possible milestone payments.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren 2024 results investor webinar on 28 February 2025
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.58%
!
$16.74

Ann: Neuren 2024 results investor webinar on 28 February 2025, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.74 |
Change
0.260(1.58%) |
Mkt cap ! $2.109B |
Open | High | Low | Value | Volume |
$16.65 | $16.90 | $16.33 | $3.468M | 207.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 368 | $16.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.74 | 368 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 246 | 16.720 |
6 | 600 | 16.710 |
4 | 458 | 16.700 |
9 | 1033 | 16.690 |
5 | 958 | 16.680 |
Price($) | Vol. | No. |
---|---|---|
16.730 | 148 | 6 |
16.740 | 699 | 8 |
16.750 | 589 | 8 |
16.760 | 496 | 6 |
16.770 | 1046 | 6 |
Last trade - 13.55pm 29/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |